Ad
Wednesday, 21 September 2016
AstraZeneca pulls cancer drug application in Europe
LONDON (Reuters) - AstraZeneca has pulled an application seeking European approval to sell its experimental cancer drug cediranib in combination with chemotherapy to treat ovarian cancer because of late-stage questions raised by regulators reviewing the product.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment